Despite the problems social, academic and behavior associated with ADHD, a child takes to be diagnosed more than two years

according to the Lifetime Impairment study in 6 European countries

-the questionnaire, with 2,500 participants, aims to assess the differences in the daily life among children with ADHD (attention deficit hyperactivity disorder) and those who do not suffer this pathology

-children with ADHD more days to class and are often the most problematic. In addition, adolescents with this disorder are more likely to have problems of conduct, such as the excessive consumption of alcohol and violence

Madrid, November 2011- survey Lifetime Impairment, sponsored by the biopharmaceutical Shire, children suffering from attention deficit with hyperactivity (ADHD) disorder presents a series of problems in their everyday lives front the norchildren without ADHD. However, the parents take an average of 26.8 months – more than two years – in get a diagnosis for your child.

The results of this study, carried out in 2010 in 6 European countries (including Spain), reveal a lower performance at school of children with ADHD: more days to class and are often the most problematic. Adults with ADHD surveyed recall that during his childhood they were not invited to social events, nor had a good relationship with his brothers.

These data, collected from the responses of adults with and without ADHD about his childhood, were analysed to reflect the daily life of patients with ADHD in a way retrospective, as well as their difficulties to reach the diagnosis and the significant difference that experiences a child with ADHD in their daily lives after treatment. He was asked, both to adults with ADHD without it on his own childhood, as well as parents and teachers.

According to the DRA. Amaia Hervás, Spanish psychiatrist child the mutual in Terrassa (Barcelona), and a participant in this analysis, these data reflect the importance of detecting those children that may be transient symptoms of inattention, impulsivity and hyperactivity or that do not cause deterioration in their lives, those who cause these symptoms associated disorder (ADHD)as this study indicates, to a significant impact on school, family and social life of the affected party. Despite the increase in recognition, diagnosis and treatment of ADHD in children, adolescents and adults in these last years in Spain, this study indicates that there is a delay in diagnosis and treatment of two years beginning ”. Other data of the study showed that teens with ADHD are more likely to have behavioral problems such as excessive consumption of alcohol and violence, etc., as stated by their parents and teachers. These data are supported by a new revision of several studies on ADHD. 281 Articles examined, ADHD presents a negative impact on major areas of life, including the academic and professional achievement, health and social behavior, and represents a significant cost to society.

Recent research also shows that ADHD affects problems such as low self-esteem, anger attacks, mood swings, cognitive and social and family relationship problems. It is also associated with increased risk to participate in criminal acts.

Study European Lifetime Impairment the European Lifetime Impairment study, sponsored by Shire, compares patients of ADHD with those who do not suffer this condition to evaluate the impact of this disorder in daily life, including the difficulties that can be found in the home, school and work, and relationships with friends and family.

The research was carried out in six European countries: Spain, France, Germany, Italy, Netherlands and United Kingdom, and was directed by a Committee of experts of ADHD in the participating countries.

Ref. Parental attention experiences of diagnosis and treatment of ADHD in children: results from the European Life Impairment Survey. Hervas, Amaia, et to the. Poster presented at the 3rd International Congress on ADHD in Berlin, Germany

Shire Pharmaceuticals

Shire Pharmaceuticals is a biopharmaceutical company with more than 20 years of experience in the health world, distributed in more than 25 countries with medicines in more than 50 countries. Shire focuses its efforts on ADHD, which accounts for more than 30% of its workforce. For more information, visit www.shireiberica.com.